This paper appears in the following:
- Early Diagnosis of Alzheimer's—Making Use of the Blood-Brain Barrier
- Madrid: News from the Vaccine Front—Phase 1 Hopefuls
- CTAD: New Data on Sola, Bapi, Spark Theragnostics Debate
- Chicago: Lilly’s Antibody Appears to Do No Harm, But Will It Help?
- St. Moritz: Part 5. Vaccine, Microglia, NGF News Fill in Neuroimmunology Picture
- Plasma Aβ as Biomarker: Not a Lost Cause, After All?
- GSAP Revisited: Does It Really Play a Role in Processing Aβ?